Glenda Burke

Statistics

Publications

Citations

H-Index

Active since

2016

Affiliations

Peter MacCallum Cancer Centre(Current)

University of Lübeck

The Royal Melbourne Hospital

Walter and Eliza Hall Institute of Medical Research

University Hospital Schleswig-Holstein

Glenda Burke is an author at Peter MacCallum Cancer Centre specializing in immunotherapy, lymphoma treatment response, and hematologic malignancy therapy.

Publications per year

2016–2024

Publications

Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions

Sasanka M. Handunnetti, Mary Ann Anderson, Kate Burbury et al. · Blood · 2024 · 22 citations · Full text

Medicine, Hematology, Oncology +8

The combination of ibrutinib and venetoclax (ABT-199) to achieve complete remissions in patients with relapsed/refractory mantle cell lymphoma: Preliminary results of the phase II AIM study.

Constantine S. Tam, Andrew W. Roberts, Mary Ann Anderson et al. · Journal of Clinical Oncology · 2016 · 13 citations

Medicine, Hematology, Pharmacotherapy +14

Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial

Lise J Estcourt, Zoe McQuilten, Peter Bardy et al. · The Lancet Haematology · 2024 · 13 citations · Full text

Medicine, Hematology, Pharmacology +13

1–3 of 3